A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study - Concepedia

Concepedia

Publication | Open Access

A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study

DOI Full Paper Access

68

Citations

25

References

2014

Year

Martín E. Stryjewski, Arnold Lentnek, William O’Riordan, John Pullman, Paul Anantharajah Tambyah, José M. Miró, Vance G. Fowler, Steven L. Barriere, Michael M. Kitt, G. Ralph Corey

BMC Infectious Diseases

Abstract

This study suggests that telavancin may have utility for treatment of uncomplicated S. aureus bacteremia; additional studies are warranted. (Telavancin for Treatment of Uncomplicated Staphylococcus Aureus Bacteremia (ASSURE); NCT00062647).

References

	Year	Citations

Page 1